Enzymatic and Chemical Synthesis for ADP-Ribosylation Using NAD+ as Building Blocks: New Concerns in Reaction Discovery and Design
- PMID: 41816858
- DOI: 10.1002/cbic.202500731
Enzymatic and Chemical Synthesis for ADP-Ribosylation Using NAD+ as Building Blocks: New Concerns in Reaction Discovery and Design
Abstract
Nicotinamide adenine dinucleotide (NAD+), as an endogenous donor for ADP-ribosylation, can modify DNA, RNA, and proteins, thereby participating in the regulation of the functions of these biomacromolecules. NAD+ serves as a reactant in both enzymatic and chemical synthesis. By employing a well-designed reaction process, the synthetic route can be significantly streamlined, enabling the preparation of structurally complex bioactive molecules in a step-saving and highly effective manner. This article reviews the latest research progress in this field. In the field of enzymatic synthesis, a strategy based on the HPF1/PARP1 complex has been developed. Earlier study shows that the recombinant HPF1/PARP1 complex can ADP-ribosylate a variety of substrates in vitro. In the field of chemical synthesis, the focus is on ionic liquid-mediated ADP-ribosylation reactions with controllable α/β configurations of products. These reactions help prepare biologically active ADP-ribosylated (ADPr) peptides from NAD+ and commercially available peptides. In addition, this article also outlines the applications of functional NAD+ derivatives in enzyme activity analysis and inhibitor development and discusses the challenges faced in this field, such as bio-compatible reaction conditions, synthesis for precise structural control, and structure-activity relationships between stereochemistry and biological functions of more ADPr derivatives.
Keywords: ADP‐ribosylation; Nicotinamide adenine dinucleotide+; chemical synthesis; chemoselectivity; enzymatic synthesis; ionic liquids.
© 2026 Wiley‐VCH GmbH.
References
-
- M. O. Hottiger, M. Boothby, F. Koch‐Nolte, et al., “Progress in the Function and Regulation of ADP‐RibosylationA Report on the 18th International Conference on ADP‐Ribosylation, Zurich, Switzerland, 18 to 21 August 2010.,” Science Signaling 4 (2011): 5.
-
- H. Wu, A. Lu, J. Yuan, Y. Yu, C. Lv, and J. Lu, “Mono‐ADP‐Ribosylation, a MARylationmultifaced Modification of Protein, DNA and RNA: Characterizations, Functions and Mechanisms,” Cell Death Discovery 10 (2024): 226.
-
- J. Groslambert, E. Prokhorova, and I. Ahel, “ADP‐Ribosylation of DNA and RNA,” DNA Repair 105 (2021): 103144.
-
- Q. Liu, G. A. van der Marel, and D. V. Filippov, “Chemical ADP‐Ribosylation: Mono‐ADPr‐Peptides and Oligo‐ADP‐Ribose,” Organic & Biomolecular Chemistry 17 (2019): 5460.
-
- H. Minnee, J. D. C. Codée, and D. V. Filippov, “Mono‐ADP‐Ribosylation of Peptides: An Overview of Synthetic and Chemoenzymatic Methodologies,” ChemBioChem 25 (2024): e202400440.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
